AKT1 and hepatocellular carcinoma: Ophiopogonin-B suppresses the PI3K/AKT pathway via downregulation of protein tyrosine phosphatase 1B (PTP1B) while activating the AMP-activated protein kinase (AMPK) pathway, leading to inhibition of HCC cell proliferation, migration, and angiogenic capabilities (95).